News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,191 Results
Type
Article (88802)
Company Profile (816)
Press Release (794550)
Multimedia
Podcasts (239)
Webinars (35)
Section
Business (233601)
Career Advice (4163)
Deals (39992)
Drug Delivery (177)
Drug Development (91719)
Employer Resources (207)
FDA (18557)
Job Trends (17487)
News (398755)
Policy (40015)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3054)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (41)
Allergies (207)
Alliances (56990)
ALS (237)
Alzheimer's disease (1974)
Antibody-drug conjugate (ADC) (557)
Approvals (18906)
Artificial intelligence (876)
ASCO (345)
Autoimmune disease (363)
Automation (64)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (85)
Breast cancer (840)
Cancer (6615)
Cardiovascular disease (560)
Career advice (3598)
Career pathing (52)
CAR-T (386)
CDC (76)
Celiac Disease (3)
Cell therapy (1075)
Cervical cancer (55)
Clinical research (79086)
Collaboration (2382)
Commercialization (1)
Company closure (8)
Compensation (1527)
Complete response letters (106)
COVID-19 (3043)
CRISPR (125)
C-suite (1297)
Cystic fibrosis (167)
Data (8772)
Decentralized trials (3)
Denatured (91)
Depression (197)
Dermatology (97)
Diabetes (709)
Diagnostics (7604)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (431)
Drug pricing (246)
Drug shortages (39)
Duchenne muscular dystrophy (319)
Earnings (102495)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138739)
Executive appointments (1199)
FDA (22649)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1954)
Gene editing (273)
Generative AI (90)
Gene therapy (854)
GLP-1 (1286)
Government (5562)
Grass and pollen (8)
Guidances (420)
Healthcare (21266)
Hematology (198)
HIV (97)
Huntington's disease (65)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (354)
Immuno-oncology (116)
Indications (211)
Infectious disease (3444)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (150)
Intellectual property (324)
Interviews (822)
IPO (18005)
IRA (61)
Job creations (5209)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (122)
Layoffs (689)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (876)
Lymphoma (478)
Machine learning (67)
Management (66)
Manufacturing (1238)
Marketing (1)
MASH (226)
Medical affairs (1)
Medical device (15283)
Medtech (15447)
Mergers & acquisitions (23300)
Metabolic disorders (1835)
mRNA (271)
Multiple sclerosis (205)
NASH (24)
Neurodegenerative disease (511)
Neuropsychiatric disorders (130)
Neuroscience (3734)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5146)
Now hiring (80)
Obesity (875)
Opinion (374)
Ovarian cancer (245)
Pain (286)
Pancreatic cancer (356)
Parkinson's disease (418)
Partnered (40)
Patents (660)
Patient recruitment (769)
Peanut (71)
People (68034)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24447)
Phase 2 (34358)
Phase 3 (25829)
Pipeline (9858)
Policy (399)
Postmarket research (3560)
Preclinical (10989)
Press Release (72)
Prostate cancer (351)
Psychedelics (71)
Radiopharmaceuticals (374)
Rare diseases (1275)
Real estate (7462)
Recruiting (81)
Regulatory (30425)
Reports (77)
Research institute (2771)
Resumes & cover letters (654)
Rett syndrome (43)
RNA editing (30)
RSV (99)
Schizophrenia (197)
Series A (330)
Series B (239)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4372)
State (2)
Stomach cancer (21)
Supply chain (148)
Tariffs (104)
The Weekly (145)
Vaccines (1313)
Venture capital (135)
Weight loss (600)
Women's health (142)
Worklife (24)
Date
Today (109)
Last 7 days (555)
Last 30 days (3011)
Last 365 days (33247)
2026 (16554)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (405)
Arkansas (16)
Asia (52320)
Australia (9196)
California (14439)
Canada (4025)
China (1586)
Colorado (622)
Connecticut (643)
Delaware (448)
Europe (120669)
Florida (2149)
Georgia (468)
Hawaii (4)
Idaho (70)
Illinois (1257)
India (104)
Indiana (667)
Iowa (26)
Japan (600)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1751)
Massachusetts (10565)
Michigan (425)
Minnesota (806)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (31)
Nevada (154)
New Hampshire (92)
New Jersey (3825)
New Mexico (35)
New York (3799)
North Carolina (1944)
North Dakota (11)
Northern California (7182)
Ohio (451)
Oklahoma (27)
Oregon (55)
Pennsylvania (2841)
Puerto Rico (31)
Rhode Island (55)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5668)
Tennessee (230)
Texas (2353)
United States (51679)
Utah (430)
Vermont (1)
Virginia (371)
Washington D.C. (89)
Washington State (1190)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,191 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short
Although Edgewise Therapeutics’ hypertrophic cardiomyopathy asset missed expectations, Truist Securities called the data “excellent,” leaning on a safety profile that could eliminate the need for risk evaluation and mitigation strategies.
June 17, 2026
·
2 min read
·
Tristan Manalac
Press Releases
NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes
June 17, 2026
·
11 min read
Press Releases
Vedana Therapeutics Launches With $46 Million Series A Financing to Advance Next-Generation Migraine Therapies
June 17, 2026
·
5 min read
Press Releases
IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors
June 17, 2026
·
3 min read
Press Releases
CTT Pharma Signs LOI with European Company
June 17, 2026
·
1 min read
Press Releases
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
June 17, 2026
·
11 min read
Press Releases
CHOP Scientists Engineer Personalized Cartilage Graft for Infants with Life-Threatening Airway Narrowing
June 17, 2026
·
5 min read
Press Releases
Christian Wichert appointed Chief Executive Officer to lead next phase of growth
June 17, 2026
·
4 min read
Artificial intelligence
Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact
Merck will use Protillion Biosciences’ tech to design biologic therapies for therapies across undisclosed indications.
June 17, 2026
·
2 min read
·
Tristan Manalac
Podcast
Moderna’s FDA adcomm, IPO mania, biopharma layoffs, more
Moderna appears to have aligned with the FDA ahead of an advisory committee meeting for its mRNA-based flu vaccine, which the regulator initially turned away in February; biotech IPOs are going gangbusters, including two new records raises in as many weeks; layoffs continue across biopharma; plus much more.
June 17, 2026
·
2 min read
·
Jef Akst
1 of 88,420
Next
